Abstract
The cytotoxic effect of tumor necrosis factor (TNF) is repressed in most cell types through the expression of several immediate–early TNF-responsive cytoprotective genes. To the best of our knowledge, there are no molecules produced under pathophysiologic condition that have been shown to override this cytoprotective effect. Identification of such molecules should contribute to our current understanding of the mechanisms underlying the pathophysiologic effects of TNF. We will argue that free heme acts in such a manner, promoting TNF-driven cytotoxicity, which might be an important component of the pathogenesis of several immune-mediated inflammatory diseases, as illustrated hereby for malaria.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- Fe:
-
iron
- JNK:
-
Jun N-terminal kinase
- NF-κB:
-
nuclear factor kappa B
References
Gozzelino R, Jeney V, Soares M (2010) Mechanisms of cell protection by heme oxygnease-1. Ann Rev Pharmacol Toxicol 50:323–354
Furuyama K, Kaneko K, Vargas PD (2007) Heme as a magnificent molecule with multiple missions: heme determines its own fate and governs cellular homeostasis. Tohoku J Exp Med 213:1–16
Tsiftsoglou AS, Tsamadou AI, Papadopoulou LC (2006) Heme as key regulator of major mammalian cellular functions: molecular, cellular, and pharmacological aspects. Pharmacol Ther 111:327–345
Mustafa AK, Gadalla MM, Snyder SH (2009) Signaling by gasotransmitters. Sci Signal 2:re2
Fenton HJH (1894) Oxidation of tartaric acid in presence of iron. Journal of the Chemical society (Lond.) 65
Balla G, Jacob HS, Balla J, Rosenberg M, Nath K, Apple F, Eaton JW, Vercellotti GM (1992) Ferritin: a cytoprotective antioxidant strategem of endothelium. Journal of Biological Chemistry 267:18148–18153
Jeney V, Balla J, Yachie A, Varga Z, Vercellotti GM, Eaton JW, Balla G (2002) Pro-oxidant and cytotoxic effects of circulating heme. Blood 100:879–887
Soares MP, Bach FH (2009) Heme oxygenase-1: from biology to therapeutic potential. Trends Mol Med 15:50–58
Ferreira A, Balla J, Jeney V, Balla G, Soares MP (2008) A central role for free heme in the pathogenesis of severe malaria: the missing link? J Mol Med 86:1097–1111
Seixas E, Gozzelino R, Chora A, Ferreira A, Silva G, Larsen R, Rebelo S, Penido C, Smith NR, Coutinho A, Soares MP (2009) Heme oxygenase-1 affords protection against noncerebral forms of severe malaria. Proc Natl Acad Sci U S A 106:15837–15842
Snow RW, Guerra CA, Noor AM, Myint HY, Hay SI. 2005. The global distribution of clinical episodes of Plasmodium falciparum malaria. Nature 434:214–217
Miller LH, Baruch DI, Marsh K, Doumbo OK (2002) The pathogenic basis of malaria. Nature 415:673–679
Mota MM, Pradel G, Vanderberg JP, Hafalla JC, Frevert U, Nussenzweig RS, Nussenzweig V, Rodriguez A (2001) Migration of Plasmodium sporozoites through cells before infection. Science 291:141–144
Prudencio M, Rodriguez A, Mota MM (2006) The silent path to thousands of merozoites: the Plasmodium liver stage. Nat Rev Microbiol 4:849–856
Bach FH, Hancock WW, Ferran C (1997) Protective genes expressed in endothelial cells – a regulatory response to injury. Immunology Today 18:483–486
Epiphanio S, Albuquerque S, Soares S, Mota MM (2005) The role of HO-1 and CO in Malaria Hepatic Stage. In ELSO Meeting. Dresden, Germany
WHO (2000) Expert Committee on Malaria: 20th Report. http://www.rbm.who.int/docs/ecr20.pdf
Idro R, Jenkins NE, Newton CR (2005) Pathogenesis, clinical features, and neurological outcome of cerebral malaria. Lancet Neurol 4:827–840
Marsh K, Forster D, Waruiru C, Mwangi I, Winstanley M, Marsh V, Newton C, Winstanley P, Warn P, Peshu N et al (1995) Indicators of life-threatening malaria in African children. N Engl J Med 332:1399–1404
Maitland K, Marsh K (2004) Pathophysiology of severe malaria in children. Acta Trop 90:131–140
Francis SE, Sullivan DJ Jr, Goldberg DE (1997) Hemoglobin metabolism in the malaria parasite Plasmodium falciparum. Annu Rev Microbiol 51:97–123
Kristiansen M, Graversen JH, Jacobsen C, Sonne O, Hoffman HJ, Law SK, Moestrup SK (2001) Identification of the haemoglobin scavenger receptor. Nature. 409:198–201
Pamplona A, Ferreira A, Balla J, Jeney V, Balla G, Epiphanio S, Chora A, Rodrigues CD, Gregoire IP, Cunha-Rodrigues M, Portugal S, Soares MP, Mota MM (2007) Heme oxygenase-1 and carbon monoxide suppress the pathogenesis of experimental cerebral malaria. Nat Med 13:703–710
Rother RP, Bell L, Hillmen P, Gladwin MT. 2005. The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease. Jama 293:1653–1662
Uko EK, Udoh AE, Etukudoh MH (2003) Methaemoglobin profile in malaria infected children in Calabar. Niger J Med 12:94–97
Bunn HF, Jandl JH (1966) Exchange of heme among hemoglobin molecules. Proc Natl Acad Sci U S A 56:974–978
Paoli M, Anderson BF, Baker HM, Morgan WT, Smith A, Baker EN (1999) Crystal structure of hemopexin reveals a novel high-affinity heme site formed between two beta-propeller domains. Nat Struct Biol 6:926–931
Fasano M, Fanali G, Leboffe L, Ascenzi P (2007) Heme binding to albuminoid proteins is the result of recent evolution. IUBMB Life 59:436–440
Allhorn M, Berggard T, Nordberg J, Olsson ML, Akerstrom B (2002) Processing of the lipocalin alpha(1)-microglobulin by hemoglobin induces heme-binding and heme-degradation properties. Blood 99:1894–901
Miller YI, Shaklai N (1999) Kinetics of hemin distribution in plasma reveals its role in lipoprotein oxidation. Biochim Biophys Acta 1454:153–164
Tolosano E, Fagoonee S, Morello N, Vinchi F, Fiorito V (2009) Heme Scavenging and the other facets of Hemopexin. Antioxid Redox Signal
Krishnamurthy P, Xie T, Schuetz JD (2007) The role of transporters in cellular heme and porphyrin homeostasis. Pharmacol Ther 114:345–358
Latunde-Dada GO, Simpson RJ, McKie AT (2006) Recent advances in mammalian haem transport. Trends Biochem Sci 31:182–188
Grau GE, Fajardo LF, Piguet PF, Allet B, Lambert PH, Vassalli P (1987) Tumor necrosis factor (cachectin) as an essential mediator in murine cerebral malaria. Science 237:1210–1212
McGuire W, Hill AV, Allsopp CE, Greenwood BM, Kwiatkowski D (1994) Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria. Nature 371:508–510
Sinha S, Mishra SK, Sharma S, Patibandla PK, Mallick PK, Sharma SK, Mohanty S, Pati SS, Ramteke BK, Bhatt R, Joshi H, Dash AP, Ahuja RC, Awasthi S, Venkatesh V, Habib S (2008) Polymorphisms of TNF-enhancer and gene for FcgammaRIIa correlate with the severity of falciparum malaria in the ethnically diverse Indian population. Malar J 7:13
Medzhitov R (2009) Damage control in host–pathogen interactions. Proc Natl Acad Sci U S A 106 15525–15526
Aggarwal BB (2003) Signalling pathways of the TNF superfamily: a double-edged sword. Nat Rev Immunol 3:745–756
Clark IA (2007) How TNF was recognized as a key mechanism of disease. Cytokine Growth Factor Rev 18:335–343
Tartaglia LA, Rothe M, Hu YF, Goeddel DV (1993) Tumor necrosis factor’s cytotoxic activity is signaled by the p55 TNF receptor. Cell 73:213–216
Wallach D, Varfolomeev EE, Malinin NL, Goltsev YV, Kovalenko AV, Boldin MP (1999) Tumor necrosis factor receptor and Fas signaling mechanisms. Annu Rev Immunol 17:331–367
Beg AA, Baltimore D (1996) An essential role for NF-kB in preventing TNF-a-induced cell death. Science 274:782–784
Churchill ME, Suzuki M (1989) ‘SPKK’ motifs prefer to bind to DNA at A/T-rich sites. Embo J 8:4189–4195
Nicholson DW, Ali A, Thornberry NA, Vaillancourt JP, Ding CK, Gallant M, Gareau Y, Griffin PR, Labelle M, Lazebnik YA et al (1995) Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 376:37–43
Kumar S, Bandyopadhyay U (2005) Free heme toxicity and its detoxification systems in human. Toxicol Lett 157:175–188
Acknowledgments
The authors thank Rasmus Larsen for invaluable help in producing the figure of this chapter as well as all members of the inflammation laboratory for critical input in the ideas and data that support the models put forward in this manuscript. This work was supported in part by “Fundação para a Ciência e Tecnologia,” Portugal grants SFRH/BPD/44256/2008 to RG, POCTI/SAU-MNO/56066/2004 and PTDC/SAU-MII/65765/2006 to MPS. Support was also provided by European Community grants, 6th Framework Xenome (LSH-2005-1.2.5-1), and by the Gemi Fund (Linde Healthcare) to MPS.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media, LLC
About this paper
Cite this paper
Gozzelino, R., Soares, M.P. (2011). Heme Sensitization to TNF-Mediated Programmed Cell Death. In: Wallach, D., Kovalenko, A., Feldmann, M. (eds) Advances in TNF Family Research. Advances in Experimental Medicine and Biology, vol 691. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-6612-4_22
Download citation
DOI: https://doi.org/10.1007/978-1-4419-6612-4_22
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4419-6611-7
Online ISBN: 978-1-4419-6612-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)